Effect of antimetabolite regimen on cellular and humoral immune response to SARS-COV-2 vaccination in solid organ transplant recipients.

Manuela CaponeAnna VanniLorenzo SalvatiGiulia LamacchiaAlessio MazzoniLaura MaggiLorenzo CosmiFrancesco LiottaPaola RomagnaniLuigi CirilloElisa ButiVito TerlizziChiara AzzariFrancesco CiteraFederica BarbatiGian Maria RossoliniSilvia BresciBeatrice BorchiAnnalisa CavalloJessica MencariniEmanuela FrancalanciSeble Tekle KirosAlessandro BartoloniFrancesco Annunziato

Published in: Immunology letters (2024)

These results, even if obtained on a small patient's cohort, question whether immunocompromised patients need interventions to improve vaccine SARS-CoV-2 mRNA vaccine response such as additional jab or modulation of immunosuppressive therapy.

Keyphrases

sars cov
end stage renal disease
ejection fraction
respiratory syndrome coronavirus
chronic kidney disease
newly diagnosed
immune response
prognostic factors
peritoneal dialysis
physical activity
case report
mesenchymal stem cells
bone marrow
binding protein
patient reported